Efficacy and safety of artemisinin-based combination therapy and the implications of Pfkelch13 and Pfcoronin molecular markers in treatment failure in Senegal

In 2006, Senegal adopted artemisinin-based combination therapy (ACT) as first-line treatment in the management of uncomplicated malaria. This study aimed to update the status of antimalarial efficacy more than ten years after their first introduction. This was a randomized, three-arm, open-label stu...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Sci Rep
Autores principales: Diallo, Mamadou Alpha, Yade, Mamadou Samb, Ndiaye, Yaye Die, Diallo, Ibrahima, Diongue, Khadim, Sy, Saidou Abdoul, Sy, Mouhamad, Seck, Mame Cheikh, Ndiaye, Mouhamadou, Dieye, Baba, Gomis, Jules François, Sow, Djiby, Dème, Awa Bineta, Badiane, Aida Sadikh, Ndiaye, Daouda
Formato: Artigo
Lenguaje:Inglês
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7264303/
https://ncbi.nlm.nih.gov/pubmed/32483161
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-020-65553-5
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares